Green Life

Project Overview

GreenLife develops an AI-driven, pesticide-free ginseng Smart Farm system that converts traditional farmland into high-productivity, sustainable bio-asset facilities. The company commercializes high-saponin organic ginseng for health foods, pharmaceuticals, cosmetics and global export, positioning its Smart Farm infrastructure as a scalable real-world productive asset for RWA investment.

Business Overview

GreenLife presents a patented Smart Farm system that enables pesticide-free, high-yield ginseng cultivation under controlled environmental conditions. Unlike traditional open-field farming, the company’s automated multi-layer facilities reduce labor by up to 96%, shorten cultivation cycles from six years to 1–2.5 years, and increase productivity through optimized temperature, humidity, and nutrient management. The resulting organic ginseng—using roots, leaves, stems, and flowers—contains dramatically higher saponin levels, including rare compounds such as F5 and Rd, which are valuable as pharmaceutical, nutraceutical, and cosmetic ingredients. This positions the company’s Smart Farm units as income-generating real-world assets (RWA) with predictable output, secured purchase agreements, and growing domestic and global demand. The business model links farmers and the company through a guaranteed buy-back system, enabling stable returns and scalable deployment. Its patented technologies, government-verified certifications, and existing distribution channels across Korea, the US, Japan, China, Vietnam, and online platforms reinforce commercialization capability. From an RWA investment perspective, each Smart Farm operates as a productive bio-infrastructure asset, generating recurring revenue through crop output and downstream value-added products such as extracts, cosmetics, and health supplements. The company’s integration of AI, biotechnology, and export-ready manufacturing creates a robust, scalable real-asset ecosystem attractive for RWA tokenization or asset-backed investment.